Abstract
Introduction: The present study aimed to evaluate the diagnostic usefulness of selected novel parameters as biomarkers of hypertension: miR-145-5p, miR-1-3p, miR-423-5p, PCSK9, MyBPC3, NOX1, and CYBb, and NCF2, DNase 1, anti-MPO and anti-PR3 antibodies. Methods: We present the data of men with normal blood pressure, diagnosed hypertension, confirmed hypertension, and hypertension and coexisting coronary artery disease. Results: Elevated levels of miR-145-5p, miR-1-3p, and miR-423-5p and high levels of PCSK9, MyBPC3, and DNase 1 were observed in all groups of hypertensive men. We showed decreased levels of NOX1 and CYBb, and an elevated level of NCF2. Conclusions: PCSK9 shows the greatest potential as an early biomarker of screening-detected hypertension.
Author supplied keywords
Cite
CITATION STYLE
Charkiewicz, A. E., Garley, M., Ratajczak-Wrona, W., Jabłońska, E., Miltyk, W., Motyka, J., & Omeljaniuk, W. J. (2022). The diagnostic potential of novel biomarkers of hypertension in men. Archives of Medical Science, 18(6), 1666–1671. https://doi.org/10.5114/aoms/153500
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.